Market Insights
The nucleic acid labeling market was estimated at USD 2.15 billion in 2022 and is likely to grow at a CAGR of 8.47% during 2023-2028 to reach USD 3.49 billion in 2028.
Want to know more about the market scope? Register Here
Market Dynamics
Introduction
Nucleic acid is defined as an important class of macromolecules that is found in all cells and viruses. It stores genetic information in biological systems. It comprises two types of namely deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Nucleic acids can be labelled with tags that enable purification or detection. Some of the commonly used labels include biotin, radioactive phosphates, fluorophores, and enzymes.
COVID-19 Impact
The COVID-19 outbreak impacted the growth of the nucleic acid labeling market positively as the polymerase chain reaction (PCR)-based molecular biology method was being widely used for the detection of coronavirus. Additionally, due to certain limitations associated with the current nucleic acid diagnostic methods, the demand for more advanced methods increased. This is likely to propel the market growth at a significant rate during the review period.
Market Drivers
The growth of the nucleic acid labeling market is primarily driven by the high prevalence of molecular disorders, which has resulted in increased demand for nucleic acid-based detection techniques.
- It is being widely used in disease risk management, prenatal tests, and infectious disease testing.
- Ongoing research and development activities to offer advanced products associated with nucleic acid detection are expected to create lucrative opportunities for the players operating in the global market.
- The lack of skilled professionals in this sector is likely to hamper the market growth.
Want to have a closer look at this market report? Click Here
Key Players
Key players operating in the market are:
- PerkinElmer, Inc. (UK),
- Enzo Biochem Inc. (The U.S),
- Vector Laboratories, Inc. (The U.S),
- F. Hoffmann LA-Roche AG (Switzerland),
- New England Biolabs (The U.S),
- Cytiva (The U.S),
- Promega Corporation (The U.S),
- Thermo Fisher Scientific Inc. (The U.S),
- Agilent Technologies, Inc. (The U.S),
- Merck KGaA (Germany).
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
Segment Analysis
Segmentations
|
List of Sub-Segments
|
Segments with High Growth Opportunity
|
Application Type Analysis
|
DNA Sequencing, Polymerase Chain Reaction, In Situ Hybridization (FISH), Microarrays, Other
|
The in-situ segment accounted for the largest market share in 2022.
|
Regional Analysis
|
North America, Europe, Asia-Pacific, and Rest of the World
|
North America accounted for the largest market share in 2022 and is expected to continue its dominance over the forecast period.
|
By Application Type
Based on application, the market has been segmented into DNA sequencing, polymerase chain reaction, in situ hybridization, microarrays, and others.
- The in-situ segment accounted for the largest market share in 2022.
- The segment growth can be attributed to the increasing use of in situ hybridization techniques in the diagnosis of various genetic disorders.
Regional Insights
Geographically, the market in North America accounted for the largest market share in 2022 and is expected to continue its dominance over the forecast period owing to the easy accessibility of new diagnostic solutions coupled with the presence of key market players such as Enzo Biochem Inc. (The U.S) and Vector Laboratories, Inc. (The U.S). The market in the Asia-Pacific region is projected to register the fastest growth during the review period on account of the increasing penetration of key players in developing countries, particularly India and China coupled with high demand for advanced diagnostic solutions.
Know the high-growth countries in this report. Register Here
Research Methodology
- This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects nucleic acid labeling market realities and future market possibilities for the forecast period.
- The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
- The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
- This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
- More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
- We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:
- Market structure: Overview, industry life cycle analysis, supply chain analysis.
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
- Market trend and forecast analysis.
- Market segment trend and forecast.
- Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
- COVID-19 impact and its recovery curve
- Attractive market segments and associated growth opportunities.
- Emerging trends.
- Strategic growth opportunities for the existing and new players.
- Key success factors.
Market Segmentation
This report studies the market, covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.
The nucleic acid labeling market is segmented into the following categories:
By Product Type
- Reagents & Kits (Labels, Probes)
- Services
By Method Type
- Enzyme-based (PCR, Others)
- Chemical-based (Conjugation, Photoreaction)
By Application Type
- DNA Sequencing
- Polymerase Chain Reaction
- In Situ Hybridization (FISH)
- Microarrays
- Others
By End-User Type
- Diagnostics
- Therapeutics
- Research
By Region
- North America (Country Analysis: the USA, Canada, and Mexico)
- Europe (Country Analysis: Germany, France, the UK, Russia, and Rest of Europe)
- Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
- Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)
Click Here, to learn the market segmentation details.
Report Customization Options
Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
- Detailed profiling of additional market players (up to 3 players)
- SWOT analysis of key players (up to 3 players)
Market Segmentation
- Current market segmentation of any one of the application types by End-User type.
Competitive Benchmarking
- Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.